Published in Medical Letter on the CDC and FDA, July 22nd, 2007
Teva's Amlodipine Besylate Tablets are the AB rated generic equivalent of Pfizer's Norvasc(R) Tablets, and are indicated for treatment of hypertension, chronic stable angina and vasospastic angina. Mylan has sued the FDA arguing that its 180-day exclusivity blocks other final approvals until September, 2007.
Total annual sales of this product are approximately $2.8 billion for the twelve...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA